Tag Archives: c. difficile

Doxycycline may provide significant protection against Clostridium difficile infections

Hospitalized patients who receive doxycycline in addition to ceftriaxone have a 79% reduced risk of Clostridium difficile infection vs patients who receive ceftriaxone only, a recent study found. “In India, the true prevalence of [C. difficile] is not known because a majority of the hospitals do not investigate for this… 

Read more »
Posted in Gastroenterology, Pharmacology, Primary Care, Women's Health | Also tagged , , , , , , , , , | Volume: | Leave a comment

Macrolide antibacterial agent fidaxomicin may be an alternative to vancomycin for Clostridium difficile-associated diarrhea

Fidaxomicin, a macrolide antibiotic, is noninferior to vancomycin in the treatment of Clostridium difficile diarrhea in terms of clinical cure. This was the main finding of a recent randomized trial that sought to demonstrate the noninferiority of fidaxomicin for this indication. C difficile, which causes 15% to 25% of antibiotic-associated… 

Read more »
Posted in Gastroenterology, Infectious Disease, Pharmacology, Primary Care | Also tagged , , , , , , , | Volume: | Leave a comment

Proton-pump inhibitors may be linked to increased risk of C. difficile-associated diarrhea

Proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD). Doctors and patients are being warned that if a patient develops diarrhea that does not improve while receiving a PPI, then CDAD should be considered as a diagnosis and managed appropriately, according to an advisory… 

Read more »
Posted in Gastroenterology, Infectious Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , , , , | Volume: | Leave a comment